SourcingAI
Try for free
Powered by Made-in-China.com
Erythromycin Eye Ointment 0.5%

Erythromycin Eye Ointment 0.5%

Guangdong, ChinaGuangzhou Sinolead Biotech Co., Ltd.
Erythromycin Eye Ointment 0.5%
US$0.10
30,000 Pieces
Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Package

1tube/Box

Compositiontetracycline HCl

Erythromycin

Model NO.

10g

Transport Package

Free

Specification

10g

Trademark

Sinolead

Origin

China

Key features

Broad Spectrum Antibiotic: Erythromycin inhibits bacterial protein synthesis to treat infections like conjunctivitis and blepharitis.
Newborn Prophylaxis: Effective for preventing ophthalmia neonatorum caused by Neisseria gonorrhoeae or Chlamydia trachomatis.
Specific Dosage Form: 0.5% concentration provided in 10g tubes, packaged as 1 tube per box.
Flexible Lead Time: Off-season lead time is within 15 workdays; peak season takes one month.
Global Export Experience: Exporting since 2005 to North America, Europe, Asia, Africa, and Oceania.
Multiple Payment Options: Supports T/T, Western Union, Money Gram, and small-amount payments.
Customized Production: Capable of customized production for generics and other pharmaceutical needs.
Sterile Application Design: Tube tip design prevents contamination; avoid touching eye or surfaces during use.

Company profile

Guangzhou Sinolead Biotech Co., Ltd.
Importers and Exporters
Guangzhou Sinolead Biotech Co., Ltd.Guangdong, China
Business Type: Manufacturer/Factory, Trading Company, Group CorporationExport Year: 2005-06-16Nearest Port: Guangzhou, Shenzhen, Hong KongAverage Response Time: ≤15hTerms of Payment: T/T, Western Union, Small-amount payment, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryThe supplier is a pharmaceutical and healthcare product manufacturer with products including glutathione, ceftriaxone sodium, amoxicillin/clavulanate, and customized generics. It reports multiple management, quality, environmental, occupational safety, and pharmaceutical certifications, along with 50 R&D engineers and 50 quality-control staff. Production information confirms several pharmaceutical dosage forms, but does not provide a directly comparable capacity figure. The supplier supports sample-based, flexible, and minor customization, but explicitly lacks ODM services, SDK availability, and recent new-product development. Service procedures exist for supplier approval, assessment, and corrective actions, although records are incomplete; complaint handling has both a clear procedure and follow-up records. It has no overseas warehouse, showroom, agents, branches, or offline trade-show experience. The company states that it has registered hundreds of pharmaceutical and healthcare products worldwide and...
Supplier typeThe supplier is positioned as a pharmaceutical and healthcare manufacturer, with listed products such as injectable ceftriaxone, glutathione, oral suspension, and customized generics. Its stated activities also include supporting product registration and regulatory dossier compliance, indicating a manufacturing-oriented pharmaceutical supplier rather than a general trading-only provider.
CertificationsThe supplier lists a broad range of certifications and management-system standards, including GMP, ISO 9001, ISO 14001, ISO 14000, HACCP, BSCI, OHSAS/OHSMS 18001, and others. The slice identifies certification holdings but does not provide certificate numbers, validity periods, or scope details.
After-Sales capabilityThe supplier has a clear complaint-handling procedure with followed records, and it accepts multiple service quotation and payment terms with stated lead times within 15 working days in both peak and off-season. However, it has no overseas warehouse, showroom, overseas agents or branches, and has no overseas-service country coverage, limiting evidence of localized after-sales support.
R&D capabilityThe supplier reports 50 R&D engineers, but explicitly states that it had no new products during the past year and no available SDK. It also does not provide ODM services, so the evidence shows established R&D staffing but limited demonstrated recent innovation.
Production capacityThe supplier lists production of multiple pharmaceutical products and dosage forms, including tablets, injections, and oral suspension, and identifies pharmaceuticals and customized generics among its product keywords. It also reports 50 quality-control staff, but the provided production-output statement is not a directly usable capacity metric for comparison.
Customization capabilityThe supplier explicitly offers customization from samples, flexible customization, and minor customization. This supports tailored production, although the supplier separately states that it does not provide ODM services.

Product Q&A

Q:What are the main indications for Erythromycin Eye Ointment?
A:
It treats bacterial conjunctivitis, blepharitis, and ocular infections caused by erythromycin-sensitive bacteria. It is also used for prophylaxis in newborns to prevent ophthalmia neonatorum.
Q:How should the ointment be applied for bacterial infections?
A:
Apply a 1 cm strip inside the lower eyelid up to 4 times daily (every 6 hours) for 7 to 10 days, or as directed by a healthcare provider.
Q:What is the dosage for newborn prophylaxis?
A:
Apply a 1 cm strip in each eye immediately after birth, typically as a single dose. Gently apply to the lower eyelid without washing off.
Q:Can I wear contact lenses while using this ointment?
A:
No. Remove contact lenses before application and avoid wearing them during treatment, as they may exacerbate the infection or interact with the medication.
Q:What are the common side effects?
A:
Some users may experience temporary stinging, blurred vision, or minor eye irritation. Serious reactions are rare but should be reported if they occur.

Send Inquiry

*To:Guangzhou Sinolead Biotech Co., Ltd.Guangzhou Sinolead Biotech Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email